1 Osteoarthritis Pain Solution Market Overview 1.1 Product Overview and Scope of Osteoarthritis Pain Solution 1.2 Osteoarthritis Pain Solution Segment by Type 1.2.1 Global Osteoarthritis Pain Solution Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Oral 1.2.3 Injection 1.2.4 External 1.3 Osteoarthritis Pain Solution Segment by Application 1.3.1 Global Osteoarthritis Pain Solution Sales Comparison by Application: (2021-2027) 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Global Osteoarthritis Pain Solution Market Size Estimates and Forecasts 1.4.1 Global Osteoarthritis Pain Solution Revenue 2016-2027 1.4.2 Global Osteoarthritis Pain Solution Sales 2016-2027 1.4.3 Osteoarthritis Pain Solution Market Size by Region: 2016 Versus 2021 Versus 2027 2 Osteoarthritis Pain Solution Market Competition by Manufacturers 2.1 Global Osteoarthritis Pain Solution Sales Market Share by Manufacturers (2016-2021) 2.2 Global Osteoarthritis Pain Solution Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Osteoarthritis Pain Solution Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Osteoarthritis Pain Solution Manufacturing Sites, Area Served, Product Type 2.5 Osteoarthritis Pain Solution Market Competitive Situation and Trends 2.5.1 Osteoarthritis Pain Solution Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Osteoarthritis Pain Solution Players Market Share by Revenue 2.5.3 Global Osteoarthritis Pain Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Osteoarthritis Pain Solution Retrospective Market Scenario by Region 3.1 Global Osteoarthritis Pain Solution Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Osteoarthritis Pain Solution Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Osteoarthritis Pain Solution Market Facts & Figures by Country 3.3.1 North America Osteoarthritis Pain Solution Sales by Country 3.3.2 North America Osteoarthritis Pain Solution Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Osteoarthritis Pain Solution Market Facts & Figures by Country 3.4.1 Europe Osteoarthritis Pain Solution Sales by Country 3.4.2 Europe Osteoarthritis Pain Solution Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Osteoarthritis Pain Solution Market Facts & Figures by Region 3.5.1 Asia Pacific Osteoarthritis Pain Solution Sales by Region 3.5.2 Asia Pacific Osteoarthritis Pain Solution Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Osteoarthritis Pain Solution Market Facts & Figures by Country 3.6.1 Latin America Osteoarthritis Pain Solution Sales by Country 3.6.2 Latin America Osteoarthritis Pain Solution Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Osteoarthritis Pain Solution Market Facts & Figures by Country 3.7.1 Middle East and Africa Osteoarthritis Pain Solution Sales by Country 3.7.2 Middle East and Africa Osteoarthritis Pain Solution Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Osteoarthritis Pain Solution Historic Market Analysis by Type 4.1 Global Osteoarthritis Pain Solution Sales Market Share by Type (2016-2021) 4.2 Global Osteoarthritis Pain Solution Revenue Market Share by Type (2016-2021) 4.3 Global Osteoarthritis Pain Solution Price by Type (2016-2021) 5 Global Osteoarthritis Pain Solution Historic Market Analysis by Application 5.1 Global Osteoarthritis Pain Solution Sales Market Share by Application (2016-2021) 5.2 Global Osteoarthritis Pain Solution Revenue Market Share by Application (2016-2021) 5.3 Global Osteoarthritis Pain Solution Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Osteoarthritis Pain Solution Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Johnson and Johnson 6.2.1 Johnson and Johnson Corporation Information 6.2.2 Johnson and Johnson Description and Business Overview 6.2.3 Johnson and Johnson Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson and Johnson Osteoarthritis Pain Solution Product Portfolio 6.2.5 Johnson and Johnson Recent Developments/Updates 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Description and Business Overview 6.3.3 GlaxoSmithKline Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GlaxoSmithKline Osteoarthritis Pain Solution Product Portfolio 6.3.5 GlaxoSmithKline Recent Developments/Updates 6.4 Bayer 6.4.1 Bayer Corporation Information 6.4.2 Bayer Description and Business Overview 6.4.3 Bayer Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bayer Osteoarthritis Pain Solution Product Portfolio 6.4.5 Bayer Recent Developments/Updates 6.5 Eli Lilly 6.5.1 Eli Lilly Corporation Information 6.5.2 Eli Lilly Description and Business Overview 6.5.3 Eli Lilly Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Eli Lilly Osteoarthritis Pain Solution Product Portfolio 6.5.5 Eli Lilly Recent Developments/Updates 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis Osteoarthritis Pain Solution Product Portfolio 6.6.5 Novartis Recent Developments/Updates 6.7 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi Osteoarthritis Pain Solution Product Portfolio 6.7.5 Sanofi Recent Developments/Updates 6.8 Horizon Pharma 6.8.1 Horizon Pharma Corporation Information 6.8.2 Horizon Pharma Description and Business Overview 6.8.3 Horizon Pharma Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Horizon Pharma Osteoarthritis Pain Solution Product Portfolio 6.8.5 Horizon Pharma Recent Developments/Updates 6.9 Abbott 6.9.1 Abbott Corporation Information 6.9.2 Abbott Description and Business Overview 6.9.3 Abbott Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Abbott Osteoarthritis Pain Solution Product Portfolio 6.9.5 Abbott Recent Developments/Updates 6.10 Mylan 6.10.1 Mylan Corporation Information 6.10.2 Mylan Description and Business Overview 6.10.3 Mylan Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Mylan Osteoarthritis Pain Solution Product Portfolio 6.10.5 Mylan Recent Developments/Updates 6.11 Daiichi Sankyo 6.11.1 Daiichi Sankyo Corporation Information 6.11.2 Daiichi Sankyo Osteoarthritis Pain Solution Description and Business Overview 6.11.3 Daiichi Sankyo Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Daiichi Sankyo Osteoarthritis Pain Solution Product Portfolio 6.11.5 Daiichi Sankyo Recent Developments/Updates 6.12 TEVA 6.12.1 TEVA Corporation Information 6.12.2 TEVA Osteoarthritis Pain Solution Description and Business Overview 6.12.3 TEVA Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.12.4 TEVA Osteoarthritis Pain Solution Product Portfolio 6.12.5 TEVA Recent Developments/Updates 6.13 Almatica Pharma 6.13.1 Almatica Pharma Corporation Information 6.13.2 Almatica Pharma Osteoarthritis Pain Solution Description and Business Overview 6.13.3 Almatica Pharma Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Almatica Pharma Osteoarthritis Pain Solution Product Portfolio 6.13.5 Almatica Pharma Recent Developments/Updates 6.14 Astellas Pharma 6.14.1 Astellas Pharma Corporation Information 6.14.2 Astellas Pharma Osteoarthritis Pain Solution Description and Business Overview 6.14.3 Astellas Pharma Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Astellas Pharma Osteoarthritis Pain Solution Product Portfolio 6.14.5 Astellas Pharma Recent Developments/Updates 6.15 Tide Pharmaceutical 6.15.1 Tide Pharmaceutical Corporation Information 6.15.2 Tide Pharmaceutical Osteoarthritis Pain Solution Description and Business Overview 6.15.3 Tide Pharmaceutical Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Tide Pharmaceutical Osteoarthritis Pain Solution Product Portfolio 6.15.5 Tide Pharmaceutical Recent Developments/Updates 6.16 Iroko Pharmaceuticals 6.16.1 Iroko Pharmaceuticals Corporation Information 6.16.2 Iroko Pharmaceuticals Osteoarthritis Pain Solution Description and Business Overview 6.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Iroko Pharmaceuticals Osteoarthritis Pain Solution Product Portfolio 6.16.5 Iroko Pharmaceuticals Recent Developments/Updates 6.17 Hengrui Pharmaceutical 6.17.1 Hengrui Pharmaceutical Corporation Information 6.17.2 Hengrui Pharmaceutical Osteoarthritis Pain Solution Description and Business Overview 6.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Hengrui Pharmaceutical Osteoarthritis Pain Solution Product Portfolio 6.17.5 Hengrui Pharmaceutical Recent Developments/Updates 6.18 Abiogen Pharma 6.18.1 Abiogen Pharma Corporation Information 6.18.2 Abiogen Pharma Osteoarthritis Pain Solution Description and Business Overview 6.18.3 Abiogen Pharma Osteoarthritis Pain Solution Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Abiogen Pharma Osteoarthritis Pain Solution Product Portfolio 6.18.5 Abiogen Pharma Recent Developments/Updates 7 Osteoarthritis Pain Solution Manufacturing Cost Analysis 7.1 Osteoarthritis Pain Solution Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Osteoarthritis Pain Solution 7.4 Osteoarthritis Pain Solution Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Osteoarthritis Pain Solution Distributors List 8.3 Osteoarthritis Pain Solution Customers 9 Osteoarthritis Pain Solution Market Dynamics 9.1 Osteoarthritis Pain Solution Industry Trends 9.2 Osteoarthritis Pain Solution Growth Drivers 9.3 Osteoarthritis Pain Solution Market Challenges 9.4 Osteoarthritis Pain Solution Market Restraints 10 Global Market Forecast 10.1 Osteoarthritis Pain Solution Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Osteoarthritis Pain Solution by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Osteoarthritis Pain Solution by Type (2022-2027) 10.2 Osteoarthritis Pain Solution Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Osteoarthritis Pain Solution by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Osteoarthritis Pain Solution by Application (2022-2027) 10.3 Osteoarthritis Pain Solution Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Osteoarthritis Pain Solution by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Osteoarthritis Pain Solution by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Osteoarthritis Pain Solution Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Osteoarthritis Pain Solution Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Osteoarthritis Pain Solution Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Osteoarthritis Pain Solution Covered in This Study Table 5. Global Osteoarthritis Pain Solution Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Osteoarthritis Pain Solution Sales Market Share by Manufacturers (2016-2021) Table 7. Global Osteoarthritis Pain Solution Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Osteoarthritis Pain Solution Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Osteoarthritis Pain Solution Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Osteoarthritis Pain Solution Manufacturing Sites and Area Served Table 11. Manufacturers Osteoarthritis Pain Solution Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Osteoarthritis Pain Solution by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Pain Solution as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Osteoarthritis Pain Solution Sales by Region (2016-2021) & (K Units) Table 16. Global Osteoarthritis Pain Solution Sales Market Share by Region (2016-2021) Table 17. Global Osteoarthritis Pain Solution Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Osteoarthritis Pain Solution Sales by Country (2016-2021) & (K Units) Table 19. North America Osteoarthritis Pain Solution Sales Market Share by Country (2016-2021) Table 20. North America Osteoarthritis Pain Solution Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Osteoarthritis Pain Solution Revenue Market Share by Country (2016-2021) Table 22. Europe Osteoarthritis Pain Solution Sales by Country (2016-2021) & (K Units) Table 23. Europe Osteoarthritis Pain Solution Sales Market Share by Country (2016-2021) Table 24. Europe Osteoarthritis Pain Solution Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Osteoarthritis Pain Solution Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Osteoarthritis Pain Solution Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Osteoarthritis Pain Solution Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Osteoarthritis Pain Solution Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Osteoarthritis Pain Solution Revenue Market Share by Region (2016-2021) Table 30. Latin America Osteoarthritis Pain Solution Sales by Country (2016-2021) & (K Units) Table 31. Latin America Osteoarthritis Pain Solution Sales Market Share by Country (2016-2021) Table 32. Latin America Osteoarthritis Pain Solution Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Osteoarthritis Pain Solution Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Osteoarthritis Pain Solution Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Osteoarthritis Pain Solution Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Osteoarthritis Pain Solution Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Country (2016-2021) Table 38. Global Osteoarthritis Pain Solution Sales (K Units) by Type (2016-2021) Table 39. Global Osteoarthritis Pain Solution Sales Market Share by Type (2016-2021) Table 40. Global Osteoarthritis Pain Solution Revenue (Million US$) by Type (2016-2021) Table 41. Global Osteoarthritis Pain Solution Revenue Share by Type (2016-2021) Table 42. Global Osteoarthritis Pain Solution Price (USD/Unit) by Type (2016-2021) Table 43. Global Osteoarthritis Pain Solution Sales (K Units) by Application (2016-2021) Table 44. Global Osteoarthritis Pain Solution Sales Market Share by Application (2016-2021) Table 45. Global Osteoarthritis Pain Solution Revenue (Million US$) by Application (2016-2021) Table 46. Global Osteoarthritis Pain Solution Revenue Share by Application (2016-2021) Table 47. Global Osteoarthritis Pain Solution Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Osteoarthritis Pain Solution Product Table 52. Pfizer Recent Developments/Updates Table 53. Johnson and Johnson Corporation Information Table 54. Johnson and Johnson Description and Business Overview Table 55. Johnson and Johnson Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Johnson and Johnson Osteoarthritis Pain Solution Product Table 57. Johnson and Johnson Recent Developments/Updates Table 58. GlaxoSmithKline Corporation Information Table 59. GlaxoSmithKline Description and Business Overview Table 60. GlaxoSmithKline Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. GlaxoSmithKline Osteoarthritis Pain Solution Product Table 62. GlaxoSmithKline Recent Developments/Updates Table 63. Bayer Corporation Information Table 64. Bayer Description and Business Overview Table 65. Bayer Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Bayer Osteoarthritis Pain Solution Product Table 67. Bayer Recent Developments/Updates Table 68. Eli Lilly Corporation Information Table 69. Eli Lilly Description and Business Overview Table 70. Eli Lilly Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Eli Lilly Osteoarthritis Pain Solution Product Table 72. Eli Lilly Recent Developments/Updates Table 73. Novartis Corporation Information Table 74. Novartis Description and Business Overview Table 75. Novartis Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Novartis Osteoarthritis Pain Solution Product Table 77. Novartis Recent Developments/Updates Table 78. Sanofi Corporation Information Table 79. Sanofi Description and Business Overview Table 80. Sanofi Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sanofi Osteoarthritis Pain Solution Product Table 82. Sanofi Recent Developments/Updates Table 83. Horizon Pharma Corporation Information Table 84. Horizon Pharma Description and Business Overview Table 85. Horizon Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Horizon Pharma Osteoarthritis Pain Solution Product Table 87. Horizon Pharma Recent Developments/Updates Table 88. Abbott Corporation Information Table 89. Abbott Description and Business Overview Table 90. Abbott Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Abbott Osteoarthritis Pain Solution Product Table 92. Abbott Recent Developments/Updates Table 93. Mylan Corporation Information Table 94. Mylan Description and Business Overview Table 95. Mylan Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Mylan Osteoarthritis Pain Solution Product Table 97. Mylan Recent Developments/Updates Table 98. Daiichi Sankyo Corporation Information Table 99. Daiichi Sankyo Description and Business Overview Table 100. Daiichi Sankyo Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Daiichi Sankyo Osteoarthritis Pain Solution Product Table 102. Daiichi Sankyo Recent Developments/Updates Table 103. TEVA Corporation Information Table 104. TEVA Description and Business Overview Table 105. TEVA Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. TEVA Osteoarthritis Pain Solution Product Table 107. TEVA Recent Developments/Updates Table 108. Almatica Pharma Corporation Information Table 109. Almatica Pharma Description and Business Overview Table 110. Almatica Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Almatica Pharma Osteoarthritis Pain Solution Product Table 112. Almatica Pharma Recent Developments/Updates Table 113. Astellas Pharma Corporation Information Table 114. Astellas Pharma Description and Business Overview Table 115. Astellas Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Astellas Pharma Osteoarthritis Pain Solution Product Table 117. Astellas Pharma Recent Developments/Updates Table 118. Tide Pharmaceutical Corporation Information Table 119. Tide Pharmaceutical Description and Business Overview Table 120. Tide Pharmaceutical Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Tide Pharmaceutical Osteoarthritis Pain Solution Product Table 122. Tide Pharmaceutical Recent Developments/Updates Table 123. Iroko Pharmaceuticals Corporation Information Table 124. Iroko Pharmaceuticals Description and Business Overview Table 125. Iroko Pharmaceuticals Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Iroko Pharmaceuticals Osteoarthritis Pain Solution Product Table 127. Iroko Pharmaceuticals Recent Developments/Updates Table 128. Hengrui Pharmaceutical Corporation Information Table 129. Hengrui Pharmaceutical Description and Business Overview Table 130. Hengrui Pharmaceutical Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Hengrui Pharmaceutical Osteoarthritis Pain Solution Product Table 132. Hengrui Pharmaceutical Recent Developments/Updates Table 133. Abiogen Pharma Corporation Information Table 134. Abiogen Pharma Description and Business Overview Table 135. Abiogen Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Abiogen Pharma Osteoarthritis Pain Solution Product Table 137. Abiogen Pharma Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Osteoarthritis Pain Solution Distributors List Table 141. Osteoarthritis Pain Solution Customers List Table 142. Osteoarthritis Pain Solution Market Trends Table 143. Osteoarthritis Pain Solution Growth Drivers Table 144. Osteoarthritis Pain Solution Market Challenges Table 145. Osteoarthritis Pain Solution Market Restraints Table 146. Global Osteoarthritis Pain Solution Sales Forecast by Type (2022-2027) & (K Units) Table 147. Global Osteoarthritis Pain Solution Sales Market Share Forecast by Type (2022-2027) Table 148. Global Osteoarthritis Pain Solution Revenue Forecast by Type (2022-2027) & (US$ Million) Table 149. Global Osteoarthritis Pain Solution Revenue Market Share Forecast by Type (2022-2027) Table 150. Global Osteoarthritis Pain Solution Sales Forecast by Application (2022-2027) & (K Units) Table 151. Global Osteoarthritis Pain Solution Sales Market Share Forecast by Application (2022-2027) Table 152. Global Osteoarthritis Pain Solution Revenue Forecast by Application (2022-2027) & (US$ Million) Table 153. Global Osteoarthritis Pain Solution Revenue Market Share Forecast by Application (2022-2027) Table 154. Global Osteoarthritis Pain Solution Sales Forecast by Region (2022-2027) & (K Units) Table 155. Global Osteoarthritis Pain Solution Sales Market Share Forecast by Region (2022-2027) Table 156. Global Osteoarthritis Pain Solution Revenue Forecast by Region (2022-2027) & (US$ Million) Table 157. Global Osteoarthritis Pain Solution Revenue Market Share Forecast by Region (2022-2027) Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Osteoarthritis Pain Solution Figure 2. Global Osteoarthritis Pain Solution Market Share by Type in 2020 & 2027 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. External Product Picture Figure 6. Global Osteoarthritis Pain Solution Market Share by Application in 2020 & 2027 Figure 7. Medical Care Figure 8. Personal Care Figure 9. Global Osteoarthritis Pain Solution Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Osteoarthritis Pain Solution Market Size 2016-2027 (US$ Million) Figure 11. Global Osteoarthritis Pain Solution Sales 2016-2027 (K Units) Figure 12. Global Osteoarthritis Pain Solution Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Osteoarthritis Pain Solution Sales Share by Manufacturers in 2020 Figure 14. Global Osteoarthritis Pain Solution Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Osteoarthritis Pain Solution Players: Market Share by Revenue in 2020 Figure 16. Osteoarthritis Pain Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Osteoarthritis Pain Solution Sales Market Share by Region (2016-2021) Figure 18. Global Osteoarthritis Pain Solution Sales Market Share by Region in 2020 Figure 19. Global Osteoarthritis Pain Solution Revenue Market Share by Region (2016-2021) Figure 20. Global Osteoarthritis Pain Solution Revenue Market Share by Region in 2020 Figure 21. U.S. Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Osteoarthritis Pain Solution Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Osteoarthritis Pain Solution by Type (2016-2021) Figure 46. Sales Market Share of Osteoarthritis Pain Solution by Application (2016-2021) Figure 47. Sales Market Share of Osteoarthritis Pain Solution by Application in 2020 Figure 48. Revenue Share of Osteoarthritis Pain Solution by Application (2016-2021) Figure 49. Revenue Share of Osteoarthritis Pain Solution by Application in 2020 Figure 50. Manufacturing Cost Structure of Osteoarthritis Pain Solution Figure 51. Manufacturing Process Analysis of Osteoarthritis Pain Solution Figure 52. Osteoarthritis Pain Solution Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Johnson and Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma